摘要
目的研究前列腺素E1治疗肝硬化的应用效果。方法方便选取该院2014年1月—2015年12月住院接受治疗的70例肝硬化病人。病人分组方法:随机抽签法。70例病人分为常规组和干预组2个组别。常规组给予内科综合治疗;干预组加前列腺素E1治疗。观察指标:1病情控制率;2治疗前和治疗后病人血清HA、LN、CIV、PcⅢ水平的差异。结果 1干预组相比于常规组病情控制率更高,χ2检验差异有统计学意义,P<0.05;2治疗前两组血清HA、LN、CIV、PcⅢ水平相似,t检验差异无统计学意义,P>0.05;治疗后干预组相比于常规组血清HA、LN、CIV、PcⅢ水平改善更显著,t检验差异有统计学意义,P<0.05。结论前列腺素E1治疗肝硬化应用效果确切,可有效延缓肝硬化进展,值得推广。
Objective To study the effect of prostaglandin E1 in the treatment of liver cirrhosis. Methods 83 cases of pa-tients with cirrhosis who were hospitalized in our hospital from January 2014 to December 2015. Patient group method：ran-dom draw.83 patients were divided into two groups： the conventional group and the intervention group. The routine group was given comprehensive treatment in the Department of internal medicine,and the intervention group was treated with prostaglandin E1.Observation index：①The disease control rate;②Before and after treatment,serum levels of HA,LN,CIV,Pc III were different. Results ①In the intervention group compared to conventional group condition control rate higher,the X2 statistic treatment there was a significant difference,P﹤0.05; ②Treatment of two groups of serum HA,LN,civ,PC III levels similar,the t statistic treatment had no significant difference （P〉0.05）;after treatment,the intervention group than in the con-ventional group blood Qing ha,LN,civ,PC III levels significantly improved,the t statistic treatment there was a significant difference,P﹤0.05）. Conclusion The effect of prostaglandin E1 in the treatment of liver cirrhosis is exact, which can effec-tively delay the progression of liver cirrhosis,and it is worth popularizing.
出处
《中外医疗》
2016年第18期135-136,共2页
China & Foreign Medical Treatment
关键词
前列腺素E1
肝硬化
应用效果
Prostaglandin El
Liver cirrhosis
Application effect
